After many trips to the doctor's office, five-year-old Burton Hayes's asthma was finally under control with a medication ...

Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics ...

To determine whether treatment of occult acid reflux is worthwhile for asthma patients, 412 adults with inadequately controlled asthma were randomized to receive the proton-pump inhibitor (PPI ...

More than 50% of patients with severe asthma have high eosinophil levels, making them candidates for biologic therapies like Nucala and other drugs like AstraZeneca’s Fasenra (benralizumab ...

Given by injection every four weeks, the drug offers an extra option for patients with the most severe symptoms, including those who suffer multiple asthma attacks. In April, NICE’s appraisal ...

It was originally approved in 2003 for the treatment of moderate to severe asthma. The drug was subsequently granted marketing authorization to treat chronic spontaneous urticaria and ...

A recent study revealed a 17.5% increase in asthma-related hospitalizations in the three months following the announcement that GSK would discontinue the widely used asthma medication Flovent, and ...

Despite changes in the approach to treatment and evidence-based medications to manage ... of the blue Saba reliever pump is a serious problem for South African asthma patients.

One in three people with asthma uses medication daily, one of them being Montelukast, more commonly known by its generic name Singulair. It is usually prescribed when asthma is mild and can stop ...